Skip to content

Contact +44 (0) 20 7060 7474 email us

Production / Manufacturing

Global Drug Manufacturing Industry Outlook to 2010: Buyer Spend and Procurement Strategies and the Impact of Recession and Recovery

 

Publication Date July 2009
Publisher Global Markets Direct
Product Type
Pages 111
ISBN Number not applicable
Product Code GMD02971

Price

£1,320.00
approximately: $1,999 | €1,473

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

"Global Drug Manufacturing Industry Outlook to 2010" is a new report published by Global Markets Direct in association with ICD Research that analyzes how drug manufacturing companies products & services spend, procurement strategies & practices and business are being affected by the recession. In an uncertain economic climate this report gives you access to the category-level spending outlooks, buyer budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also identifies buyers and suppliers future growth, M&A and investment expectations. The research is based on an extensive survey of senior and C-level industry executives from our market leading panels.

Scope

  • The opinions and forward looking statements of over 550 industry executives have been captured in our in-depth survey, of which 65% represent Directors, C-levels & Departmental Heads
  • This report covers data and analysis on buyer spend, procurement and industry developments by pharmaceutical process and manufacturing, biopharma, biotech, public sector pharma, CRO and CMO companies and leading suppliers worldwide
  • The report examines current practices and provides future expectations over the next 12-24 months
  • The research is based on primary survey research conducted by Global Markets Direct in association with ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations
  • Key topics covered include buyer spend activity, procurement behaviors & strategies and how these have been affected by the recession, threats & opportunities for the drug manufacturing industry, economic outlook and business confidence.
  • In the report buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats
  • The report provides qualitative analysis of the key industry threats and opportunities and contains full survey results
  • The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle East

Highlights

  • 40% of drug manufacturers expect to increase their procurement spend over the next 12 months, a further 22% looking to maintain it at current levels, however with many claiming to be re-evaluating their supplier base the market open to competition is expected to increase over the coming year
  • 38% of buyers are seeking to engage in partnerships to optimize working capital and reduce costs - closer cooperation between suppliers and buyers is being sought during this time of market uncertainty
  • Only 14% of drug manufacturers do not regularly evaluate suppliers to ensure they meet high ethical and environmental standards

Reasons to buy

  • Drive revenues by understanding future product investment areas and growth regions by leading industry players
  • Formulate effective sales & marketing strategies by identifying how buyer budgets are changing and where spend will be directed to in the future
  • Better promote your business by aligning your capabilities and business practices with your customer's changing needs during these times of market uncertainty
  • Secure stronger customer relationships by understanding the leading business concerns and changing strategies of buyers in the pharmaceutical industry
  • Effectively plan your business strategies
  • Predict how the industry will grow, consolidate and where it will stagnate
  • Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers in the industry

Contents

  • 1 Table Of Contents
    • 1.1 List Of Tables
    • 1.2 List Of Figures
  • 2 Introduction
    • 2.1 What is This Report About?
    • 2.2 Methodology
    • 2.3 Profile Of Survey Respondents
  • 3 Executive Summary
  • 4 Economic Outlook & Confidence
    • 4.1 Global Economy Recovery Expectations
    • 4.2 Revenue Growth Expectations
  • 5 Drug Manufacturing Industry Investment Outlook
    • 5.1 Fastest & Slowest Growing Markets
    • 5.2 M&A Activity Predictions
    • 5.3 Supplier's Industry Outlook
  • 6 Recession: Threats & Opportunities For The Drug Manufacturing Industry
    • 6.1 Leading Business Concerns Due To Recession
    • 6.2 Key Actions To Overcome Business Threats
    • 6.3 Key Actions To Maintain & Win Buyer Business
    • 6.4 Leading Recession-Related Business Opportunities
  • 7 Drug Manufacturing Industry Buyer Spend Activity
    • 7.1 Annual Procurement Budgets
    • 7.2 Expected Change In Procurement Spend
    • 7.3 Expected Change In Spend By Product & Service Category
  • 8 Procurement Behaviors & Strategies & The Impact Of Recession
    • 8.1 Critical Success Factors For Supplier Selection
    • 8.2 Current Effects Of Recession On Procurement Objectives
    • 8.3 Expected Future Effects Of Recession On Procurement Objectives
    • 8.4 The Effects Of Recession On Procurement Strategy
  • 9 Appendix
    • 9.1 Full Survey Results
    • 9.2 Methodology
    • 9.3 Contact Us
    • 9.4 About Global Markets Direct
    • 9.5 Disclaimer
    • 1.1 List Of Tables
    • Table 1: Count Of Global Drug Manufacturing Industry Survey Respondents By Company Type (Number Of Respondents), 2009 Industry Survey
    • Table 2: Buyer Respondents By Job Role (% Buyer Respondents), Global Drug Manufacturing Industry, 2009
    • Table 3: Buyer Respondents By Organization's Global Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009
    • Table 4: Buyer Respondents By Organization's Total Employee Size (% Buyer Respondents), Global Drug Manufacturing Industry, 2009
    • Table 5: Supplier Respondents By Job Role (% Supplier Respondents), Global Drug Manufacturing Industry, 2009
    • Table 6: Supplier Respondents By Organization's Global Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009
    • Table 7: Supplier Respondents By Organization's Total Employee Size (% Supplier Respondents), Global Drug Manufacturing Industry, 2009
    • Table 8: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009
    • Table 9: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009
    • Table 10: Company Revenue Growth Optimism By Global Drug Manufacturing Industry Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009
    • Table 11: Company Revenue Growth Optimism In The Global Drug Manufacturing Industry By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009
    • Table 12: Drug Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturer Respondents), 2009
    • Table 13: Drug Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturing Industry Supplier Respondents), 2009
    • Table 14: Drug Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturing Industry Supplier Respondents), 2009
    • Table 15: Key Growth Areas In The Drug Manufacturing Industry (Analysis Of Supplier Respondents), 2009 Industry Survey
    • Table 16: Key Growth Areas In The Drug Manufacturing Industry - Senior Level Responses Only , 2009 Industry Survey
    • Table 17: Key Declining Areas In The Drug Manufacturing Industry (Analysis Of Supplier Respondents), 2009 Industry Survey
    • Table 18: Key Declining Areas In The Drug Manufacturing Industry - Senior Level Responses Only , 2009 Industry Survey
    • Table 19: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization Vs. Drug Manufacturing Industry Supplier: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009
    • Table 20: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009
    • Table 21: Most Important Actions Being Implemented By The Drug Manufacturing Industry To Overcome Leading Business Concerns In 2009-2010 (Analysis Of All Respondents), 2009 Industry Survey
    • Table 22: Most Important Actions Being Implemented By Drug Manufacturing Industry Buyers To Overcome Leading Business Concerns In 2009-2010 - Senior Level Responses Only, 2009 Industry Survey
    • Table 23: Most Important Actions Being Implemented By Drug Manufacturing Industry Buyers To Overcome Leading Business Concerns In 2009-2010 (Analysis Of Buyer Respondents), 2009 Industry Survey
    • Table 24: Most Important Actions Being Implemented By Drug Manufacturing Industry Suppliers To Overcome Leading Business Concerns In 2009-2010 (Analysis Of Supplier Respondents), 2009 Industry Survey
    • Table 25: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Supplier Responses Versus All Buyer Responses (% All Respondents), 2009
    • Table 26: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), 2009
    • Table 27: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of Buyer Respondents By Company Turnover (% Buyer Respondents), 2009
    • Table 28: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Procurement Budget (% Buyer Respondents), 2009
    • Table 29: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Region (% Buyer Respondents), 2009
    • Table 30: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Purchasing Decision Seniority (% Buyer Respondents Purchasing Decision Influence), 2009
    • Table 31: Leading Business Opportunities For The Drug Manufacturing Industry During The Recession (Analysis Of All Respondents), 2009 Industry Survey
    • Table 32: Leading Business Opportunities For The Drug Manufacturing Industry During The Recession - Senior Level Responses Only, 2009 Industry Survey
    • Table 33: Leading Business Opportunities For Drug Manufacturing Industry Buyers During The Recession (Analysis Of Buyer Respondents), 2009 Industry Survey
    • Table 34: Leading Business Opportunities For Drug Manufacturing Industry Suppliers During The Recession (Analysis Of Supplier Respondents), 2009 Industry Survey
    • Table 35: Annual Procurement Budgets In US$ In The Global Drug Manufacturing Industry: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Table 36: Annual Procurement Budgets In US$ In The Global Drug Manufacturing Industry By Region (% All Buyer Respondents), 2009
    • Table 37: Expected Change In Spend On Products & Services In The Global Drug Manufacturing Industry Over The Next 12 Months: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Table 38: Expected Change In Spend On Products & Services In The Global Drug Manufacturing Industry Over The Next 12 Months By Region (% All Buyer Respondents), 2009
    • Table 39: Future Change In Spend In The Global Drug Manufacturing Industry By Product And Service Category: Expected Increase Or Decrease Over The Next 12 Months Among Drug Manufacturers (% Drug Manufacturer Respondents), 2009
    • Table 40: Future Change In Spend In The Global Drug Manufacturing Industry By Product And Service Category: Expected Increase Or Decrease Over The Next 12 Months Among Contract Research Organizations / Contract Manufacturing Organizations (% CRO/CMO Respondents), 2009
    • Table 41: Critical Success Factors For Selecting A Drug Manufacturing Industry Supplier: Buyer Versus Supplier Comparison (% All Respondents), 2009
    • Table 42: Critical Success Factors For Selecting A Drug Manufacturing Industry Supplier: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization Comparison (% All Buyer Respondents), 2009
    • Table 43: Current Effects Of Recession On Procurement Objectives & Priorities In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Table 44: Current Effects Of Recession On Procurement Objectives & Priorities In The Global Drug Manufacturing Industry By Company Turnover (% All Buyer Respondents), 2009
    • Table 45: Expected Changes In Procurement Strategy In The Global Drug Manufacturing Industry To Drive Value Across The Business Due To Recession: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Table 46: Expected Changes In Procurement Strategy In The Global Drug Manufacturing Industry To Drive Value Across The Business Due To Recession: All Buyers By Company Turnover (% All Buyer Respondents), 2009
    • Table 47: Expected Changes In Procurement Strategy In The Global Drug Manufacturing Industry To Drive Value Across The Business Due To Recession: All Buyers By Purchasing Decision Seniority (% All Buyer Respondents Purchasing Decision Influence), 2009
    • Table 48: Expected Changes In Procurement Strategy In The Global Drug Manufacturing Industry To Drive Value Across The Business Due To Recession: All Buyers By Region (% All Respondents), 2009
    • Table 49: Buyer Attitudes & Approaches To Existing Procurement Practices Among Drug Manufacturers: Level Of Agreement To The Following 5 Statements (% Drug Manufacturer Respondents), 2009
    • Table 50: Attitudes & Approaches To Existing Procurement Practices Among Contract Research Organizations / Contract Manufacturing Organizations: Level Of Agreement To The Following 5 Statements (% CRO/CMO Respondents), 2010
    • Table 51: Full Survey Results
    • 1.2 List Of Figures
    • Figure 1: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009
    • Figure 2: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings (% All Respondents), 2009
    • Figure 3: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009
    • Figure 4: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009
    • Figure 5: Company Revenue Growth Optimism In The Global Drug Manufacturing Industry (% All Respondents), 2009
    • Figure 6: Company Revenue Growth Optimism By Global Drug Manufacturing Industry Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009
    • Figure 7: Company Revenue Growth Optimism In The Global Drug Manufacturing Industry By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009
    • Figure 8: Drug Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturer Respondents), 2009
    • Figure 9: Outsource Industry (Contract Research Organization / Contract Manufacturing Organization): Market Predictions Of The Fastest And Slowest Growing Regions (% Contract Research Organization / Contract Manufacturing Organization Respondents), 2009
    • Figure 10: Drug Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturing Industry Supplier Respondents), 2009
    • Figure 11: Merger & Acquisition Activity Expectations Over The Next 12 Months In The Global Drug Manufacturer Industry (% Drug Manufacturer Industry Respondents), 2009
    • Figure 12: Merger & Acquisition Activity Expectations Over The Next 12 Months In The Global Outsource Industry: Contract Research Organization / Contract Manufacturing Organization (% Contract Research Organization / Contract Manufacturing Organization Industry Respondents), 2009
    • Figure 13: Merger & Acquisition Activity Expectations Over The Next 12 Months In The Global Drug Manufacturing Industry Supplier Industry (% Drug Manufacturing Industry Supplier Industry Respondents), 2009
    • Figure 14: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009
    • Figure 15: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization Vs. Drug Manufacturing Industry Supplier: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009
    • Figure 16: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Supplier Responses Versus All Buyer Responses (% All Respondents), 2009
    • Figure 17: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), 2009
    • Figure 18: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Region (% Buyer Respondents), 2009
    • Figure 19: Annual Procurement Budgets In US$ In The Global Drug Manufacturing Industry: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Figure 20: Annual Procurement Budgets In US$ In The Global Drug Manufacturing Industry By Company Turnover (% All Buyer Respondents), 2009
    • Figure 21: Annual Procurement Budgets In US$ In The Global Drug Manufacturing Industry By Region (% All Buyer Respondents), 2009
    • Figure 22: Expected Change In Spend On Products & Services In The Global Drug Manufacturing Industry Over The Next 12 Months: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Figure 23: Expected Change In Spend On Products & Services In The Global Drug Manufacturing Industry Over The Next 12 Months By Company Turnover (% All Buyer Respondents), 2009
    • Figure 24: Expected Change In Spend On Products & Services In The Global Drug Manufacturing Industry Over The Next 12 Months By Region (% All Buyer Respondents), 2009
    • Figure 25: Future Change In Spend In The Global Drug Manufacturing Industry By Product And Service Category: Expected Increase Or Decrease Over The Next 12 Months Among Drug Manufacturers (% Drug Manufacturer Respondents), 2009
    • Figure 26: Future Change In Spend In The Global Drug Manufacturing Industry By Product And Service Category: Expected Increase Or Decrease Over The Next 12 Months Among Contract Research Organizations / Contract Manufacturing Organizations (% CRO/CMO Respondents), 2009
    • Figure 27: Future Change In Spend In The Global Drug Manufacturing Industry By Product And Service Category: Expected Increase Over The Next 12 Months Among Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Figure 28: Future Change In Spend In The Global Drug Manufacturing Industry By Product And Service Category: Expected Increase Over The Next 12 Months Among All Buyers By Company Turnover (% All Buyer Respondents), 2009
    • Figure 29: Future Change In Spend In The Global Drug Manufacturing Industry By Product And Service Category: Expected Increase Over The Next 12 Months Among All Buyers By Region (% All Buyer Respondents), 2009
    • Figure 30: Critical Success Factors For Selecting A Drug Manufacturing Industry Supplier: Difference In Views, Buyers Versus Suppliers (Net Difference In Ranking), 2009
    • Figure 31: Critical Success Factors For Selecting A Drug Manufacturing Industry Supplier: Buyer Versus Supplier Comparison (% All Respondents), 2009
    • Figure 32: Critical Success Factors For Selecting A Drug Manufacturing Industry Supplier: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization Comparison (% All Buyer Respondents), 2009
    • Figure 33: Current Effects Of Recession On Procurement Objectives & Priorities In The Global Drug Manufacturing Industry (% All Buyer Respondents), 2009
    • Figure 34: Current Effects Of Recession On Procurement Objectives & Priorities In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Figure 35: Likelihood Of Future Change In Procurement Objectives In The Global Drug Manufacturing Industry (% All Buyer Respondents), 2009
    • Figure 36: Likelihood Of Future Change On Procurement Objectives In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Figure 37: Likelihood Of Future Change On Procurement Objectives In The Global Drug Manufacturing Industry By Company Turnover (% All Buyer Respondents), 2009
    • Figure 38: Expected Future Effects Of Recession On Procurement Objectives & Priorities In The Global Drug Manufacturing Industry (% All Buyer Respondents), 2009
    • Figure 39: Expected Future Effects Of Recession On Procurement Objectives & Priorities In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Figure 40: Expected Future Effects Of Recession On Procurement Objectives & Priorities In The Global Drug Manufacturing Industry By Company Turnover (% All Buyer Respondents), 2009
    • Figure 41: Expected Changes In Procurement Strategy In The Global Drug Manufacturing Industry To Drive Value Across The Business Due To Recession (% All Buyer Respondents), 2009
    • Figure 42: Expected Changes In Procurement Strategy In The Global Drug Manufacturing Industry To Drive Value Across The Business Due To Recession: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% All Buyer Respondents), 2009
    • Figure 43: Expected Changes In Procurement Strategy In The Global Drug Manufacturing Industry To Drive Value Across The Business Due To Recession: All Buyers By Region (% All Buyer Respondents), 2009